over time differed by insurance type. (Psychiatric Services 64: , 2013; doi: / appi.ps )
|
|
- Tyrone Dwayne Richards
- 7 years ago
- Views:
Transcription
1 Brief Reports National TrendsintheUseof Antidepressants Between 1997 and 2009 and the Role of Medicare Part D Implementation Dooyoung Lim, M.H.A. Kyoungrae Jung, Ph.D. Yunfeng Shi, Ph.D. Objectives: This study examined national trends in antidepressant use before and after implementation of Medicare Part D and compared utilization among individuals with different types of insurance. Methods: Thedatasourcewasthe Medical Expenditure Panel Survey Household Component ( ), and logistic regression was used for the analysis. Results: The odds of antidepressant use among people with depression increased between 1997 and 2009 in each insurance group (Medicare: adjusted odds ratio [AOR]53.30, 95% confidence interval [CI] ; Medicaid: AOR52.97, CI ; dually eligible for Medicare and Medicaid: AOR52.24, CI ; and private coverage: AOR56.63, CI ). The odds of antidepressant use after implementation of Part D increased more among Medicare beneficiaries than among Medicaid beneficiaries (AOR51.35, CI ). Conclusions: The use of antidepressants among people with depression increased in all insurance groups up to 2009; however, the patterns of utilization and the degree of increase The authors are affiliated with the Department of Health Policy and Administration, College of Health and Human Development, Pennsylvania State University, University Park, Pennsylvania. Send correspondence to Dr. Jung at the department, 604 Ford Building, University Park, PA ( kuj11@psu.edu). over time differed by insurance type. (Psychiatric Services 64: , 2013; doi: / appi.ps ) Depression is a common chronic disorder that affects all age groups of the United States population (1). Because of the distress and the poor physical condition that often accompany depressive symptoms, persons with depression have low quality of life (2). As a result, their use of health care and expenditures for health care are higher than for people without depression (3). Thus proper treatment for depression is important to improve patients wellbeing and to help reduce health care use and spending. Antidepressant medications are commonly recommended as a treatment for depressive symptoms (4). During the 1990s and early 2000s, there was a nationwide trend toward increasing use of antidepressant treatment. Studies from nationally representative samples reported that antidepressant use among persons who received outpatient treatment for depression increased from 37% in 1987 to 75% in 2007 (5,6). This significant increase was attributed in part to the introduction of newer antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), which are safer and have fewer side effects than traditional tricyclic antidepressants (TCAs) (7). In addition, the use of direct-to-consumer advertising of antidepressant medications was found to be associated with the initiation of the treatment (8). Building on this prior literature, our study used data from 1997 to 2009 to examine more recent national trends in the use of antidepressants among people with depression. In particular, our analysis encompassed the implementation of Medicare Part D, which provides prescription drug coverage to Medicare beneficiaries and is expected to increase the consumption of prescription drugs. This major policy change, which took effect in 2006, has had the potential to affect antidepressant utilization, particularly among Medicare beneficiaries. To date, little is known about national trends in antidepressant treatment after Part D. Chen and others (9) examined the impact of Part D on antidepressant use among Medicare beneficiaries; however, the study s analysis was limited to 2006, the initial year of Part D. Another study reported that between 2004 and 2007, antidepressant utilization increased by 61% among Medicare beneficiaries who gained prescription drug coverage through Part D (10). However, the sample was limited to Part D enrollees of a single managed-care plan. Our study analyzed trends in antidepressant use in nationally representative samples between 1997 and Moreover, we characterized patterns of antidepressant treatment by insurance source, which so far has not been examined in the literature. We also assessed whether antidepressant treatment after Part 1038 PSYCHIATRIC SERVICES ' ps.psychiatryonline.org ' October 2013 Vol. 64 No. 10
2 D was significantly different among Medicare beneficiaries than among people covered by other types of insurance. Methods We used multiyear data ( ) from the Medical Expenditure Panel Survey Household Component (MEPS- HC), which includes five rounds of interviews over two and a half years involving a nationally representative sample of noninstitutionalized U.S. residents (11). The data include information on health care utilization (type, frequency, expenditure, and payer) and sociodemographic characteristics of respondents and their families. We identified individuals with depression by using MEPS-HC medical conditions files. The survey asks respondents to describe their medical conditions. From this self-reported information, professional coders recorded individuals medical conditions by using the International Classification of Diseases, ninth revision, Clinical Modification (ICD-9- CM). Persons with ICD-9-CM codes 296 or 311 recorded for any round of interviews was defined as having had depression during that calendar year (12). The MEPS-HC prescribed medicines file provides self-reported information on medication use. We identified antidepressants by drug names, including TCAs (amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, maprotiline, mirtazapine, nortriptyline, and protriptyline); SSRIs (citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline); and others (bupropion, duloxetine, nefazodone, selegiline, trazodone, and venlafaxine) (12). We constructed a binary variable representing whether the respondent had at least one of these medications during a calendar year. A key variable of the analysis was insurance coverage. We categorized the type of insurance into four mutually exclusive groups: Medicare, Medicaid, dual coverage for Medicare and Medicaid (dual eligible), and private coverage. We excluded uninsured people, whose pattern of health care service use may be so different from that of insured populations as to make ready comparison difficult. Covariates used in the analysis were age, race (white, black, and Hispanic), gender, education, family income, and health risk. The education variable was classified as zero to 12 years, 13 to 15 years, and 16 or more years. Family income was grouped as #124% of the federal poverty level (FPL), 125%2199% of the FPL, 200%2 399% of the FPL, and 400% or more of the FPL. Health risk was measured by chronic condition indicators and the number of prescription drugs taken by a patient. [Descriptive statistics of all covariates reported by insurance group are available online in a data supplement to this report.] We analyzed the trends in antidepressant use over time by using logistic regression controlling for sociodemographic factors. We included dummy variables for year to capture the trend in treatment between 1997 and Using 1997 as the base year, we obtained the adjusted odds ratios (AORs) of antidepressant use for all subsequent years. The analysis was conducted for each insurance group. Standard errors were clustered within an individual in all analyses to account for repeated interviews of the individual that occurred because of the panel survey design. Next, we examined the effect of Part D on the use of antidepressants among Medicare beneficiaries by estimating a logistic model with an interaction term between the Part D and Medicare indicators. The Part D indicator equaled 1 if the year was 2006 or after and 0 if the year was before The Medicare indicator equaled 1 if the patient was covered by Medicare and 0 if not. Our main interest was the coefficient of this interaction, which indicated whether the changes in antidepressant use after Part D were significantly different among Medicare beneficiaries than among other groups. This is known as the difference-in-difference (DD) estimator. We obtained DD estimates for Medicare and all other insurance groups combined as well as for Medicare and each of the other three insurance groups. We controlled for all patient characteristics, and we adjusted standard errors for clustering within an individual. Results The percentage of people using antidepressants increased in all insurance groups between 1997 and The Medicare group had a large increase in 2006 but showed a somewhat stable trend after that, while the privately insured group had a consistent increase from the early 2000s up to The Medicaid group showed a relatively slow increase compared with the other insurance groups. [A figure depicting unadjusted trends in antidepressant use by insurance coverage is available online as a data supplement to this report.] Table 1 presents the results of a regression analysis of the trend in use of antidepressants by insurance group. The estimates by year dummies indicated increasing use of antidepressants during the study period in all groups. The odds of use of antidepressants in the Medicare group significantly increased in 2006 relative to 1997 (AOR52.52), potentially reflecting the impact of Part D. However, AORs remained relatively stable from 2007 through 2009 (between 2.69 and 3.30). The odds of antidepressant use increased significantly in the Medicaid group starting in 2005 and in the dual-eligible group starting in AORs in the private coverage group increased continuously from 2002 up to 2009 and reached their highest levels in 2008 (AOR54.81) and 2009 (AOR56.63). For other covariates, older people were more likely than younger people to take antidepressants in the Medicaid and private coverage groups. Whites had significantly greater odds of using antidepressants than blacks in the Medicare and privately covered groups. The effects of education and income were mostly insignificant. Table 2 shows the results from the regression examining whether use of antidepressant treatment after Part D increased more in the Medicare group than in the other groups. With Medicaid as the control group, the analysis indicated that the interaction term between Part D and Medicare indicators was significant (AOR51.35). This implies that the increase in the PSYCHIATRIC SERVICES ' ps.psychiatryonline.org ' October 2013 Vol. 64 No
3 Table 1 Odds of antidepressant use over time among persons with depression, by type of insurance Medicare (N52,252) Medicaid (N54,728) Dual eligible (N51,587) Private coverage (N514,025) Covariate AOR 95% CI p AOR 95% CI p AOR 95% CI p AOR 95% CI p Year (reference: 1997) , , , , , , , , , ,.001 Age , ,.001 Female (reference: male) Race (reference: white) Black ,.001 Hispanic Education (years) (reference: 0 12) Family income (reference: #124% of FPL a ) 125% 199% of FPL % 399% of FPL $400% of FPL Chronic condition indicator High blood pressure Heart disease , , High cholesterol Diabetes Joint pain Arthritis Asthma Medications (N) , , , ,.001 a Federal poverty level 1040 PSYCHIATRIC SERVICES ' ps.psychiatryonline.org ' October 2013 Vol. 64 No. 10
4 Table 2 Odds of antidepressant treatment after implementation of Medicare Part D among Medicare beneficiaries versus beneficiaries with other insurance a Medicare vs. non Medicare Medicare vs. Medicaid Medicare vs. dual eligible Medicare vs. private coverage Variable AOR 95% CI p AOR 95% CI p AOR 95% CI p AOR 95% CI p Part D b , ,.001 Medicare Part D 3 Medicare a All regression models include year dummies and respondents health and sociodemographic factors. b Part D indicator represents years 2006 and later. odds of taking antidepressants after Part D was significantly larger among Medicare beneficiaries than in the Medicaid group. The interaction term in other analyses was insignificant. Discussion The use of antidepressants between 1997 and 2009 increased in all insurance groups. This overall increasing trend is encouraging; however, our analysis indicates that the rate of utilization and the degree of the increase over time differed by insurance group. The Medicaid group showed a lower rate of utilization and a slightly slower increase in utilization over time than were seen in other groups. Our study did not explore reasons for these differences or the appropriateness of utilization in each group. However, the assessment of the treatment pattern is the first step toward ensuring the use of effective services. Further research is necessary to assess the need for antidepressant treatment and the level of appropriate use in each insurance group. Our analysis showed that Part D led to a greater use of antidepressants among Medicare beneficiaries, compared with the Medicaid group. This positive effect of Part D on antidepressant treatment is consistent with the prior literature (9,10). However, the large increase seems to have occurred mostly during the initial year of Part D, which suggests that further evaluations of Part D are needed to better understand its long-term impact. We did not find a significant increase in the use of antidepressants among Medicare beneficiaries after Part D compared with dual-eligible or privately covered populations. This suggests that there may have been interventions to improve antidepressant use in those non-medicare groups during the post Part D period. Identifying mechanisms through which other insurance (non-medicare) groups improved drug utilization is an important topic for future research. A few limitations of the study should be noted. First, we relied on self-reported medical conditions to identify patients with depression, which raises a concern that receiving antidepressant treatment was a determinant of self-reporting depression. If this were the case, we would have observed an increase in the number of people with depression but little or no increase in the rate of antidepressant use. However, our data indicate that the depression population did not grow as antidepressant use increased over time, suggesting that such a concern was unlikely. Second, our analysis was limited to the insured population. The use of depression treatment is likely to be low among the uninsured, a population that needs extensive attention and interventions. However, we excluded persons without insurance because they may exhibit systematically different characteristics that do not allow for appropriate comparison with the insured. Third, although MEPS is a methodologically rigorous survey, it is subject to reporting errors, potentially because of recall problems among the respondents. However, there is no conclusive evidence that those errors systematically differ among insurance groups or change over time, and the impact of reporting errors on our findings of the trends, if any, was likely to have been insignificant. Conclusions The use of antidepressants among people with depression increased continuously in all insurance groups up to Increases after Part D were larger among Medicare beneficiaries than among Medicaid beneficiaries. The different patterns of utilization and trends over time among insurance groups suggest that further research is needed to explore the reasons for those differences and to assess levels of appropriate use of antidepressants by insurance group. Acknowledgments and disclosures The authors thank Dennis Shea, Ph.D., for thoughtful comments on an earlier version of this article. The authors report no competing interests. References 1. Li C, Ford ES, Zhao G, et al: A comparison of depression prevalence estimates measured by the Patient Health Questionnaire with two administration modes: computer-assisted telephone interviewing versus computer-assisted personal interviewing. International Journal of Public Health 57: , Spitzer RL, Kroenke K, Linzer M, et al: Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 Study. JAMA 274: , Simon GE, VonKorff M, Barlow W: Health care costs of primary care patients with recognized depression. Archives of General Psychiatry 52: , American Psychiatric Association: Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry 157 (April suppl):1 45, 2000 PSYCHIATRIC SERVICES ' ps.psychiatryonline.org ' October 2013 Vol. 64 No
5 5. Olfson M, Marcus SC, Druss B, et al: National trends in the outpatient treatment of depression. JAMA 287: , Marcus SC, Olfson M: National trends in the treatment for depression from 1998 to Archives of General Psychiatry 67: , Anderson IM: SSRIs versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depression and Anxiety 7(suppl 1):11 17, Donohue JM, Berndt ER, Rosenthal M, et al: Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Medical Care 42: , Chen H, Nwangwu A, Aparasu R, et al: The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors. Psychiatric Services 59: , Donohue JM, Zhang Y, Aiju M, et al: Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. American Journal of Geriatric Psychiatry 19: , Cohen SB: Sample Design of the 1996 Medical Expenditure Panel Survey Household Component. Rockville, Md, Agency for Healthcare Research and Quality, Harman JS, Edlund MJ, Fortney JC: Disparities in the adequacy of depression treatment in the United States. Psychiatric Services 55: , PSYCHIATRIC SERVICES ' ps.psychiatryonline.org ' October 2013 Vol. 64 No. 10
What are the best treatments?
What are the best treatments? Description of Condition Depression is a common medical condition with a lifetime prevalence in the United States of 15% among adults. Symptoms include feelings of sadness,
More informationMember Rights & Responsibilities
Member Rights & Responsibilities Member Rights and Responsibilities Blue KC has updated our Member Rights & Responsibilities to be consistent across all of our HMO and PPO products. Blue KC members have:
More informationkaiser medicaid uninsured commission on The Role of Medicaid for People with Behavioral Health Conditions November 2012
on on medicaid and and the the uninsured November 2012 The Role of Medicaid for People with Behavioral Health Conditions Introduction Behavioral health conditions encompass a broad range of illnesses,
More informationAntidepressants and suicidal thoughts and behaviour. Pharmacovigilance Working Party. January 2008
Antidepressants and suicidal thoughts and behaviour Pharmacovigilance Working Party January 2008 PhVWP PAR January 2008 Page 1/15 1. Introduction The Pharmacovigilance Working Party has on a number of
More informationSTATISTICAL BRIEF #95
Medical Expenditure Panel Survey STATISTICAL BRIEF #95 Agency for Healthcare Research and Quality September 2005 Statin Use among Persons 18 and Older in the U.S. Civilian Noninstitutionalized Population
More informationTREATING MAJOR DEPRESSIVE DISORDER
TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.
More informationResearch. Dental Services: Use, Expenses, and Sources of Payment, 1996-2000
yyyyyyyyy yyyyyyyyy yyyyyyyyy yyyyyyyyy Dental Services: Use, Expenses, and Sources of Payment, 1996-2000 yyyyyyyyy yyyyyyyyy Research yyyyyyyyy yyyyyyyyy #20 Findings yyyyyyyyy yyyyyyyyy U.S. Department
More informationRacial Disparities and Barrier to Statin Utilization in Patients with Diabetes in the U.S. School of Pharmacy Virginia Commonwealth University
Racial Disparities and Barrier to Statin Utilization in Patients with Diabetes in the U.S. School of Pharmacy Virginia Commonwealth University Outline Background Motivation Objectives Study design Results
More informationEnrollment under the Medicaid Expansion and Health Insurance Exchanges. A Focus on Those with Behavioral Health Conditions in Maine
Enrollment under the Medicaid Expansion and Health Insurance Exchanges A Focus on Those with Behavioral Health Conditions in Maine Data Sources National Survey on Drug Use and Health Sponsored by SAMHSA
More informationRural-Urban Differences in Depression Care
Rural-Urban Differences in Depression Care John C. Fortney Jeffrey S. Harman Stanley Xu Fran Dong October 2009 Working Paper Western Interstate Commission for Higher Education Mental Health Program 3035
More informationEnrollment under the Medicaid Expansion and Health Insurance Exchanges. A Focus on Those with Behavioral Health Conditions in Indiana
Enrollment under the Medicaid Expansion and Health Insurance Exchanges A Focus on Those with Behavioral Health Conditions in Indiana Data Sources National Survey on Drug Use and Health Sponsored by SAMHSA
More informationMedical expenditures of work-related injuries among immigrant workers in USA
Medical expenditures of work-related injuries among immigrant workers in USA Huiyun Xiang, MD, MPH, PhD Associate Professor Director for International Programs Center for Injury Research and Policy The
More informationEnrollment under the Medicaid Expansion and Health Insurance Exchanges. A Focus on Those with Behavioral Health Conditions in Washington
Enrollment under the Medicaid Expansion and Health Insurance Exchanges A Focus on Those with Behavioral Health Conditions in Washington Data Sources National Survey on Drug Use and Health Sponsored by
More informationNear-Elderly Adults, Ages 55-64: Health Insurance Coverage, Cost, and Access
Near-Elderly Adults, Ages 55-64: Health Insurance Coverage, Cost, and Access Estimates From the Medical Expenditure Panel Survey, Center for Financing, Access, and Cost Trends, Agency for Healthcare Research
More informationEnrollment under the Medicaid Expansion and Health Insurance Exchanges. A Focus on Those with Behavioral Health Conditions in Florida
Enrollment under the Medicaid Expansion and Health Insurance Exchanges A Focus on Those with Behavioral Health Conditions in Florida Data Sources National Survey on Drug Use and Health Sponsored by SAMHSA
More informationEnrollment under the Medicaid Expansion and Health Insurance Exchanges. A Focus on Those with Behavioral Health Conditions in Georgia
Enrollment under the Medicaid Expansion and Health Insurance Exchanges A Focus on Those with Behavioral Health Conditions in Georgia Data Sources National Survey on Drug Use and Health Sponsored by SAMHSA
More informationMedicare- Medicaid Enrollee State Profile
Medicare- Medicaid Enrollee State Profile Kentucky Centers for Medicare & Medicaid Services Introduction... 1 At a Glance... 1 Eligibility... 2 Demographics... 3 Chronic Conditions... 4 Utilization...
More informationEnrollment under the Medicaid Expansion and Health Insurance Exchanges. A Focus on Those with Behavioral Health Conditions in Idaho
Enrollment under the Medicaid Expansion and Health Insurance Exchanges A Focus on Those with Behavioral Health Conditions in Idaho Data Sources National Survey on Drug Use and Health Sponsored by SAMHSA
More informationEnrollment under the Medicaid Expansion and Health Insurance Exchanges. A Focus on Those with Behavioral Health Conditions in New Hampshire
Enrollment under the Medicaid Expansion and Health Insurance Exchanges A Focus on Those with Behavioral Health Conditions in New Hampshire Data Sources National Survey on Drug Use and Health Sponsored
More informationUpdate on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice
Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological
More informationMedicare- Medicaid Enrollee State Profile
Medicare- Medicaid Enrollee State Profile Centers for Medicare & Medicaid Services Introduction... 1 At a Glance... 1 Eligibility... 2 Demographics... 3 Chronic Conditions... 4 Utilization... 6 Spending...
More informationDisclosures Christer Allgulander
How Patients With Generalized Anxiety Disorder (GAD) Are Treated in Specialized Care: A Pharmacoepidemiological Case Register Study in Sweden Christer Allgulander MD, Karolinska Institutet, Sweden Jan
More informationDepression Flow Chart
Depression Flow Chart SCREEN FOR DEPRESSION ANNUALLY Assess for depression annually with the PHQ-9. Maintain a high index of suspicion in high risk older adults. Consider suicide risk and contributing
More informationProposed New Measures for HEDIS 1 Learning Collaborative: Depression Care Measures Set
Draft Document for HEDIS 2016 Public Comment Obsolete After March 18, 2015 1 Proposed New Measures for HEDIS 1 Learning Collaborative: Depression Care Measures Set NCQA s theme for 2015 our 25th anniversary
More informationHealth Status, Health Insurance, and Medical Services Utilization: 2010 Household Economic Studies
Health Status, Health Insurance, and Medical Services Utilization: 2010 Household Economic Studies Current Population Reports By Brett O Hara and Kyle Caswell Issued July 2013 P70-133RV INTRODUCTION The
More informationMerrile Sing. Agency for Healthcare Research and Quality Working Paper No. 08011. December 2008
Benchmarking Medicare Managed Care Plan Enrollment Estimates from the Medical Expenditure Panel Survey and Administrative Enrollment Files from the Centers for Medicare & Medicaid Services Merrile Sing
More informationPOPULAR DEPRESSION MEDICATIONS
Popular Depression Medications A Helpful Guide to Antidepressant Drugs POPULAR DEPRESSION MEDICATIONS A Helpful Guide to Antidepressant Drugs Popular Depression Medications A Helpful Guide to Antidepressant
More informationUNINSURED ADULTS IN MAINE, 2013 AND 2014: RATE STAYS STEADY AND BARRIERS TO HEALTH CARE CONTINUE
UNINSURED ADULTS IN MAINE, 2013 AND 2014: RATE STAYS STEADY AND BARRIERS TO HEALTH CARE CONTINUE December 2015 Beginning in January 2014, the federal Patient Protection and Affordable Care Act (ACA) has
More informationDepression. Medicines To Help You
Medicines To Help You Depression Use this guide to help you talk to your doctor, pharmacist, or nurse about your medicines for depression. The guide lists all of the FDA-approved products now available
More informationJessica S. Banthin and Thomas M. Selden. Agency for Healthcare Research and Quality Working Paper No. 06005. July 2006
Income Measurement in the Medical Expenditure Panel Survey Jessica S. Banthin and Thomas M. Selden Agency for Healthcare Research and Quality Working Paper No. 06005 July 2006 Suggested citation: Banthin
More informationA Burden or Merely a Load: New Empirical Estimates of Health Insurance Loading Fees by Group Size
A Burden or Merely a Load: New Empirical Estimates of Health Insurance Loading Fees by Group Size Pinar Karaca-Mandic, University of Minnesota Jean M. Abraham, University of Minnesota Charles E. Phelps,
More informationINSIGHT on the Issues
INSIGHT on the Issues AARP Public Policy Institute Medicare Beneficiaries Out-of-Pocket for Health Care Claire Noel-Miller, PhD AARP Public Policy Institute Medicare beneficiaries spent a median of $3,138
More informationSTATISTICAL BRIEF #143
Medical Expenditure Panel Survey STATISTICAL BRIEF #143 Agency for Healthcare Research and Quality September 26 Health Insurance Status of Hispanic Subpopulations in 24: Estimates for the U.S. Civilian
More informationIs Health Care Spending Higher under Medicaid or Private Insurance?
Jack Hadley John Holahan Is Health Care Spending Higher under Medicaid or Private Insurance? This paper addresses the question of whether Medicaid is in fact a high-cost program after adjusting for the
More informationDisparities in Realized Access: Patterns of Health Services Utilization by Insurance Status among Children with Asthma in Puerto Rico
Disparities in Realized Access: Patterns of Health Services Utilization by Insurance Status among Children with Asthma in Puerto Rico Ruth Ríos-Motta, PhD, José A. Capriles-Quirós, MD, MPH, MHSA, Mario
More informationWhite Paper. Medicare Part D Improves the Economic Well-Being of Low Income Seniors
White Paper Medicare Part D Improves the Economic Well-Being of Low Income Seniors Kathleen Foley, PhD Barbara H. Johnson, MA February 2012 Table of Contents Executive Summary....................... 1
More informationHealthcare Utilization by Individuals with Criminal Justice Involvement: Results of a National Survey
Healthcare Utilization by Individuals with Criminal Justice Involvement: Results of a National Survey Frank JW, Linder JA, Becker WC, Fiellin DA, Wang EA Background U.S. criminal justice population is
More informationNational Findings on Access to Health Care and Service Use for Non-elderly Adults Enrolled in Medicaid
National Findings on Access to Health Care and Service Use for Non-elderly Adults Enrolled in Medicaid By Sharon K. Long Karen Stockley Elaine Grimm Christine Coyer Urban Institute MACPAC Contractor Report
More informationMedicare- Medicaid Enrollee State Profile
Medicare- Medicaid Enrollee State Profile Montana Centers for Medicare & Medicaid Services Introduction... 1 At a Glance... 1 Eligibility... 2 Demographics... 3 Chronic Conditions... 4 Utilization... 6
More informationPharmaSUG2011 Paper HS03
PharmaSUG2011 Paper HS03 Using SAS Predictive Modeling to Investigate the Asthma s Patient Future Hospitalization Risk Yehia H. Khalil, University of Louisville, Louisville, KY, US ABSTRACT The focus of
More informationTREATMENT-RESISTANT DEPRESSION AND ANXIETY
University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2
More informationMedicare Beneficiaries Out-of-Pocket Spending for Health Care
Insight on the Issues OCTOBER 2015 Beneficiaries Out-of-Pocket Spending for Health Care Claire Noel-Miller, MPA, PhD AARP Public Policy Institute Half of all beneficiaries in the fee-for-service program
More informationSECTION M BEHAVIORAL HEALTH SERVICES
Phoenix Health Plan s (PHP) goal for its members is to ensure that behavioral health services are readily available for Title XIX (Medicaid) and the Title XXI (KidsCare) members. Comprehensive behavioral
More informationSTATISTICAL BRIEF #87
Agency for Healthcare Medical Expenditure Panel Survey Research and Quality STATISTICAL BRIEF #87 July 2005 Attitudes toward Health Insurance among Adults Age 18 and Over Steve Machlin and Kelly Carper
More informationNon-Emergent Emergency Department Use among Adults with Disabilities
Non-Emergent Emergency Department Use among Adults with Disabilities June 8, 2014 David Idala, Nancy Miller, Adele Kirk, Charles Betley, Seung Kim, Yi-An Chen, Ming Liang Dai Introduction Disparities in
More informationANTIDEPRESSANT MEDICINES. A GUIDE for ADULTS With DEPRESSION
ANTIDEPRESSANT MEDICINES A GUIDE for ADULTS With DEPRESSION August 2007 FAST FACTS ON ANTIDEPRESSANTS The antidepressants in this guide work for treating depression. Most people can find one that makes
More informationMedicare- Medicaid Enrollee State Profile
Medicare- Medicaid Enrollee State Profile North Centers for Medicare & Medicaid Services Introduction... 1 At a Glance... 1 Eligibility... 2 Demographics... 3 Chronic Conditions... 4 Utilization... 6 Spending...
More informationMedicines for Treating Depression. A Review of the Research for Adults
Medicines for Treating Depression A Review of the Research for Adults Is This Information Right for Me? Yes, if: A doctor or other health care professional has told you that you have depression. Your doctor
More informationSTATISTICAL BRIEF #378
STATISTICAL BRIEF #378 July 212 Asthma Medication Use among Adults with Reported Treatment for Asthma, United States, and 28-29 Frances M. Chevarley, PhD Introduction Asthma is a chronic respiratory disease
More informationContinuity of Antidepressant Treatment for Adults With Depression in the United States
Article Continuity of Antidepressant Treatment for Adults With Depression in the United States Mark Olfson, M.D., M.P.H. Steven C. Marcus, Ph.D. Michael Tedeschi, R.Ph., M.B.A. George J. Wan, Ph.D., M.P.H.
More informationSTATISTICAL BRIEF #167
Medical Expenditure Panel Survey STATISTICAL BRIEF #167 Agency for Healthcare Research and Quality March 27 The Five Most Costly Conditions, 2 and 24: Estimates for the U.S. Civilian Noninstitutionalized
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More informationMedicare Prescription Drug Benefit Progress Report:
Chartpack Medicare Prescription Drug Benefit Progress Report: Findings from the Kaiser/Commonwealth/Tufts-New England Medical Center 2006 National Survey of Seniors and Prescription Drugs August 2007 Methodology
More informationEfficacy and Tolerability of Antidepressant Duloxetine for Treatment of Hot Flushes in Menopausal Women
Efficacy and Tolerability of Antidepressant Duloxetine for Treatment of Hot Flushes in Menopausal Women Irina Shestakova, MD, PhD Research Center of Obstetrics, Gynecology and Perinatology Department of
More informationRisk Adjustment: Implications for Community Health Centers
Risk Adjustment: Implications for Community Health Centers Todd Gilmer, PhD Division of Health Policy Department of Family and Preventive Medicine University of California, San Diego Overview Program and
More informationAccess Provided by your local institution at 02/06/13 5:22PM GMT
Access Provided by your local institution at 02/06/13 5:22PM GMT brief communication Reducing Disparities in Access to Primary Care and Patient Satisfaction with Care: The Role of Health Centers Leiyu
More informationMedical Care Costs for Diabetes Associated with Health Disparities Among Adults Enrolled in Medicaid in North Carolina
No. 160 August 2009 Among Adults Enrolled in Medicaid in North Carolina by Paul A. Buescher, Ph.D. J. Timothy Whitmire, Ph.D. Barbara Pullen-Smith, M.P.H. A Joint Report from the and the Office of Minority
More informationWhy are antidepressants used to treat IBS? Some medicines can have more than one action (benefit) in treating medical problems.
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD What are functional GI disorders? There are more
More informationDepressive disorders among older residents in a Chinese rural community. Risk for Depression by Age and Sex. Risk for Depression by Age and Sex
Risk for Depression by Age and Sex Risk for Depression by Age and Sex Depressive disorders among older residents in a Chinese rural community. Liu CY, et al: Psychological Medicine 1997:27: 943-949 Male
More informationSTATISTICAL BRIEF #113
Medical Expenditure Panel Survey STATISTICAL BRIEF #113 Agency for Healthcare Research and Quality January 26 Children s Dental Care: Periodicity of Checkups and Access to Care, 23 May Chu Introduction
More informationResearch Brief. Dental Care Utilization Rate Highest Ever among Children, Continues to Decline among Working-Age Adults. Key Messages.
Dental Care Utilization Rate Highest Ever among Children, Continues to Decline among Working-Age Adults Authors: Kamyar Nasseh, Ph.D.; Marko Vujicic, Ph.D. The Health Policy Institute (HPI) is a thought
More informationBehavioral Health Barometer. United States, 2014
Behavioral Health Barometer United States, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
More informationProblems Paying Medical Bills Among Persons Under Age 65: Early Release of Estimates From the National Health Interview Survey, 2011 June 2015
Problems Paying Medical Bills Among Persons Under Age 65: Early Release of Estimates From the National Health Interview Survey, June 5 by Robin A. Cohen, Ph.D., and Jeannine S. Schiller, M.P.H. Division
More informationMeasuring Generic Efficiency in Part D
Measuring in Part D Rates among Medicare Part D Generic efficiency rate is a measurement of the total number of prescrip=ons filled as a generic for products with a direct generic subs=tute within a therapeu=c
More information(4) To characterize the course of illness after adequate response to and continuation on the treatments found effective for individual participants.
I. Specific Aims/Objectives STAR*D has several main objectives and is powered to assess the effectiveness of a sequence of treatments at various levels of treatment. Most of these objectives entail evaluating
More informationResearch Brief. Physician Visits After Hospital Discharge: Implications for Reducing Readmissions. Readmissions, Not Just a Medicare Problem
Research Brief NUMBER 6 DECEMBER 2011 Physician Visits After Hospital Discharge: Implications for Reducing Readmissions BY ANNA SOMMERS AND PETER J. CUNNINGHAM Public and private payers view reducing avoidable
More informationLouisiana Report 2013
Louisiana Report 2013 Prepared by Louisiana State University s Public Policy Research Lab For the Department of Health and Hospitals State of Louisiana December 2015 Introduction The Behavioral Risk Factor
More informationMajor Depression Medication Adherence Tool Kit
Major Depression Medication Adherence Tool Kit Major Depression Medication Adherence Tool Kit One of the keys to successfully managing major depression is medication adherence. VSHP has developed a new
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
More informationMedication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center
Medication Management of Depressive Disorders in Children and Adolescents Satya Tata, M.D. Kansas University Medical Center First Line Medications SSRIs Prozac (Fluoxetine): 5-605 mg Zoloft (Sertraline):
More informationOverview of Mental Health Medication Trends
America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription
More informationManaging Patients with Pain, Psychiatric Co-Morbidity & Addiction
Managing Patients with Pain, Psychiatric Co-Morbidity & Addiction John A. Renner Jr., MD, CAS Division of Psychiatry Boston University School of Medicine Prescribers Clinical Support System for Opioid
More informationElderly males, especially white males, are the people at highest risk for suicide in America.
Statement of Ira R. Katz, MD, PhD Professor of Psychiatry Director, Section of Geriatric Psychiatry University of Pennsylvania Director, Mental Illness Research Education and Clinical Center Philadelphia
More informationHealth Care Utilization and Costs of Full-Pay and Subsidized Enrollees in the Florida KidCare Program: MediKids
Health Care Utilization and Costs of Full-Pay and Subsidized Enrollees in the Florida KidCare Program: MediKids Prepared for the Florida Healthy Kids Corporation Prepared by Jill Boylston Herndon, Ph.D.
More informationAccess to Health Services
Ah Access to Health Services Access to Health Services HP 2020 Goal Improve access to comprehensive, quality health care services. HP 2020 Objectives Increase the proportion of persons with a usual primary
More informationEffect of Anxiety or Depression on Cancer Screening among Hispanic Immigrants
Racial and Ethnic Disparities: Keeping Current Seminar Series Mental Health, Acculturation and Cancer Screening among Hispanics Wednesday, June 2nd from 12:00 1:00 pm Trustees Conference Room (Bulfinch
More informationSTATISTICAL BRIEF #173
Medical Expenditure Panel Survey STATISTICAL BRIEF #173 Agency for Healthcare Research and Quality June 27 Use of the Pap Test as a Cancer Screening Tool among Women Age 18 64, U.S. Noninstitutionalized
More information2012 Vermont Household Health Insurance Survey: Comprehensive Report
Vermont Department of Financial Regulation Insurance Division 2012 Vermont Household Health Insurance Survey: Comprehensive Report Brian Robertson, Ph.D. Jason Maurice, Ph.D. Table of Contents Page I.
More informationPSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that
More informationfind out about... tricyclic antidepressants a publication from
find out about... tricyclic antidepressants a publication from Why have I been prescribed this drug? Tricyclic and related Antidepressants (TCAs) are prescribed for people suffering from depression or
More informationOne Program, Two Populations: A Comparison of Disabled Workers and Retirees in Medicare
One Program, Two Populations: A Comparison of Disabled Workers and Retirees in Medicare Jae Kennedy, PhD Darren Liu, DrPH Josh Engle, MHPA Liz Blodgett, MHPA (cand) WSU Dept. of Health Policy and Administration
More informationChartpack. August 2008
Chartpack Examining Sources of Coverage Among Medicare Beneficiaries: Supplemental Insurance, Medicare Advantage, and Prescription Drug Coverage Findings from the Medicare Current Beneficiary Survey, 2006
More informationRacial and Ethnic Differences in Health Insurance Coverage and Usual Source of Health Care, 2002
MEPS Chartbook No. 14 Medical Expenditure Panel Survey Racial and Ethnic Differences in Health Insurance Coverage and Usual Source of Health Care, 2002 Medical Expenditure Panel Survey Agency for Healthcare
More informationCMS Publishes Star Ratings Reflecting Medicare Advantage Plan Quality
Rachel Reid, MS 1 ; Benjamin Howell, PhD 2 ; Partha Deb, PhD 2 ; William Shrank, MD MSHS 2 1 University of Pittsburgh School of Medicine, 2 CMS Innovation Center AcademyHealth 2012 Annual Research Meeting
More information8/14/2012 California Dual Demonstration DRAFT Quality Metrics
Stakeholder feedback is requested on the following: 1) metrics 69 through 94; and 2) withhold measures for years 1, 2, and 3. Steward/ 1 Antidepressant medication management Percentage of members 18 years
More informationWho are most likely to visit hospital emergency departments (EDs)?
Research Brief The Methodist Le Bonheur Center for Healthcare Economics July 2015 Visitors to Hospital Emergency Rooms: Who, Why, and How Much Do They Cost? Cyril F. Chang, Ph.D. Introduction Hospital
More informationTask 7: Study of the Uninsured and Underinsured
75 Washington Avenue, Suite 206 Portland, Maine04101 Phone: 207-767-6440 Email: research@marketdecisions.com www.marketdecisions.com Task 7: Study of the Uninsured and Underinsured Vermont Office of Health
More informationThe Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs
The Role of Insurance in Providing Access to Cardiac Care in Maryland Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs Heart Disease Heart Disease is the leading cause of death
More informationBehavioral Health Barometer. United States, 2013
Behavioral Health Barometer United States, 2013 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
More informationQuick Turnaround with Administrative Health Data
Quick Turnaround with Administrative Health Data Katherine Giuriceo, PhD Research and Rapid Cycle Evaluation Group Center for Medicare and Medicaid Innovation, CMS October 2, 2015 1 Overview Center for
More informationDoes referral from an emergency department to an. alcohol treatment center reduce subsequent. emergency room visits in patients with alcohol
Does referral from an emergency department to an alcohol treatment center reduce subsequent emergency room visits in patients with alcohol intoxication? Robert Sapien, MD Department of Emergency Medicine
More informationHealth Care Expenditures for Uncomplicated Pregnancies
Health Care Expenditures for Uncomplicated Pregnancies Agency for Healthcare Research and Quality U.S. Department of Health & Human Services August 2007 ABSTRACT This report uses data pooled from three
More informationMajor Depressive Disorder:
Major Depressive Disorder: An Actuarial Commercial Claim Data Analysis July 2013 Prepared by: Milliman, Inc. NY Kate Fitch RN, MEd Kosuke Iwasaki FIAJ, MAAA, MBA This report was commissioned by Takeda
More informationPersonal Health Information Management and the Design of Consumer Health Information Technology
Personal Health Information Management and the Design of Consumer Health Information Technology Secondary Analysis of Data From the Medical Expenditure Panel Survey Prepared for: Agency for Healthcare
More informationClinical Practice Guideline: Depression in Primary Care, Adult 4 Taft Court Rockville, MD 20850 www.mamsi.com
Clinical Practice Guideline: Depression in 4 Taft Court Rockville, MD 20850 www.mamsi.com 40 05 17 035 3/03 Once a primary care patient presents with depressive symptoms, the primary care physician makes
More information